Delivery Order SPE2DR25D1103-SPE2DR26FF078
- Not listed
- The Defense Logistics Agency (DLA) awarded a $31,949.98 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,442.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $14,675.36. This firm fixed-price delivery order, awarded on June 30, 2025, with a completion date of July 1, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,901.84 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count package) with a completion date of December 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply framework with the federal government. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.81 to Amerisourcebergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count) on January 27, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order will be completed by January 28, 2026. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) with a contract ceiling value of $7,416.21. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,049.32 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on April 21, 2025, with an ultimate completion date of April 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $89,553.56 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on January 30, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical supplier to federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,956.18 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8 count) on January 6, 2026, with completion scheduled for January 7, 2026. This firm fixed-price, competitively awarded delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed on a full and open basis among qualified...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FF078Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,422.65 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) on February 2, 2026, with completion expected by February 3, 2026. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare systems globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The arrangement enables AmerisourceBergen to efficiently fulfill critical pharmaceutical needs for military treatment facilities and other federal medical institutions through flexible task order mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/1/26 |